Virus News and Research

Latest Virus News and Research

Unlocking the anti-inflammatory secrets of bergamot byproducts

The positive effect of bergamot derivatives.

17 Jan 2024

Vaccination provides moderate protection against long COVID in children

Vaccination against SARS-CoV-2, the virus that causes COVID-19, reduces the risk of serious acute illness in children and adolescents.

16 Jan 2024

Large UK study highlights gaps in COVID-19 vaccine coverage

The first research study of the entire UK population highlights gaps in COVID-19 vaccine coverage. Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022.

16 Jan 2024

New Omicron variants relearn immunity dodging tricks

Recent SARS-CoV-2 variants such as BA.4 and BA.5 developed abilities missing from the first Omicron variants that allowed them to overcome humans' innate immunity, according to research from UCL.

16 Jan 2024

Research uncovers why antibodies can boost snake venom

What makes a soldier switch sides? That is a really good question. Especially when the soldier is an antibody that is supposed to defend the body against one of the world's most dangerous snake venoms but instead ends up helping the venom kill the body.

16 Jan 2024

Simple measures in the health care setting could prevent SARS-CoV-2 transmission

In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious and pathogenic virus, made its alarming debut and quickly spread worldwide, causing the novel coronavirus (COVID-19) pandemic that threatened human health and public safety.

16 Jan 2024

Pandemic shifts: Ontario children's hospital visits and admissions down during COVID-19

Despite major disruptions to health care systems during the COVID-19 pandemic, there was no significant increase in preventable conditions or deaths in children according to a large study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221726.

16 Jan 2024

Amsterdam UMC project aims for first effective HIV vaccine with Gates funding

Worldwide, an estimated, 40 million people live with HIV. Two-thirds of this group on the African continent.

16 Jan 2024

What would a second Trump presidency look like for health care?

On the presidential campaign trail, former President Donald Trump is, once again, promising to repeal and replace the Affordable Care Act — a nebulous goal that became one of his administration's splashiest policy failures.

16 Jan 2024

Study finds that HIV populations in people with higher viral loads also have higher rates of viral recombination

Researchers investigated whether denser intrahost HIV populations had a higher incidence of coinfection and recombination.

15 Jan 2024

Universal Coronavirus vaccine could save billions in U.S., new study suggests

The epidemiologic, clinical, and economic value of a universal coronavirus disease 2019 (COVID-19) vaccine.

15 Jan 2024

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce the economic burden by US $170.17 billion in the US.

14 Jan 2024

JN.1 variant's spread not due to enhanced immune escape, study suggests

Study finds the JN.1 variant of SARS-CoV-2 may not have increased immune escape ability compared to its predecessor BA.2.86, suggesting other factors for its rapid spread.

14 Jan 2024

Study explores intratumoral microbiota as a novel frontier in cancer research

Researchers review the role of intratumoral microbiota in cancer development, suggesting its potential in predicting and treating various cancers.

14 Jan 2024

Novel type 2 oral polio vaccine secures WHO prequalification for broader rollout

The novel type 2 oral polio vaccine (nOPV2), developed by a team including scientists from the Medicines and Healthcare products Regulatory Agency (MHRA), has today (9 January) been quality-assured (prequalified) by the World Health Organization (WHO).

13 Jan 2024